← All organizations

Consortium for Improving Survival of Lymphoma

Academic/Hospital

Also known as: Consortium for Improving Survival on Lymphoma

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 1, 2017

Timeline

No events for the selected filters.

Drugs by trial phase (8 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

naltrexone

Phase 2 (7 own, 0 via acquisition)

Indications

Studied for

Recent trials (4)

NCT03123718CollaboratorPhase 3Jul 1, 2017
NCT03052933CollaboratorPhase 1/Phase 2May 1, 2017
NCT02840539CollaboratorPhase 2Oct 1, 2016
NCT01448096CollaboratorPhase 2Aug 1, 2011

Details

Last known activity: Jul 1, 2017